Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal
Year: 2014
Type: article
Source: Biological Psychiatry
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institute on Drug Abuse
Awards: G100873256, Cannabinergic Ligands and Drugs, Molecular Basis of Cannabinoid Activity, Optimizing analgesia by exploiting CB2 agonist functional selectivity, Cannabinergic Medications for Methamphetamine Addiction, Neuronal cannabinoids, AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA, MOLECULAR BASIS OF CANNABINOID ACITIVITY, Cannabinoid Modulation of Cell Function, Protein-protein interaction inhibitors as novel analgesics, Endocannabinoid Active Sites as Therapeutic Targets
OpenAlex ID: W2071991061
